REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$70.70
0.00%
(0.00) 1D
Sep 4, 4:56:00 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
R$71.55
High
R$71.55
Low
R$70.70
Mkt. cap
85.22B
Avg. vol.
863.00
Volume
1.14K
52-wk high
R$73.13
52-wk low
R$49.06
Shares outstanding
101.14M
No. of employees
15K
Open
R$71.55
High
R$71.55
Low
R$70.70
Mkt. cap
85.22B
Avg. vol.
863.00
Volume
1.14K
52-wk high
R$73.13
52-wk low
R$49.06
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
AD HOC NEWS
·
26 minutes ago
Regeneron stock slips on a $85.2 billion market value
The Motley Fool
·
1 day ago
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
https://www.dars.gov.et/
·
2 weeks ago
Regeneron (REGN) Results Review: Profit Per Share Clears Its Benchmark in the Current Update; Closing Reaction
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com